Authors:
Vandamme, AM
Houyez, F
Banhegyi, D
Clotet, B
De Schrijver, G
De Smet, KAL
Hall, WW
Harrigan, R
Hellmann, N
Hertogs, K
Holtzer, C
Larder, B
Pillay, D
Race, E
Schmit, JC
Schuurman, R
Shulse, E
Sonnerborg, A
Miller, V
Citation: Am. Vandamme et al., Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up, ANTIVIR TH, 6(1), 2001, pp. 21-39
Authors:
Matthews, GV
Pillay, D
Cane, P
Ratcliffe, D
Gazzard, B
Nelson, M
Citation: Gv. Matthews et al., Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1, CLIN INF D, 33(12), 2001, pp. 2049-2054
Authors:
Porter, K
Pillay, D
Cane, P
Dean, G
Churchill, D
Baily, G
Drake, S
Fisher, M
Citation: K. Porter et al., Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom, BR MED J, 322(7294), 2001, pp. 1087-1088
Authors:
Taylor, S
Back, DJ
Drake, SM
Workman, J
Reynolds, H
Gibbons, SE
White, DJ
Pillay, D
Citation: S. Taylor et al., Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir, J ANTIMICRO, 48(3), 2001, pp. 351-354
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
Taylor, S
Reynolds, H
Sabin, CA
Drake, SM
White, DJ
Back, DJ
Pillay, D
Citation: S. Taylor et al., Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men, AIDS, 15(15), 2001, pp. 2051-2053
Authors:
Govinden, R
Pillay, B
van Zyl, WH
Pillay, D
Citation: R. Govinden et al., Xylitol production by recombinant Saccharomyces cerevisiae expressing the Pichia stipitis and Candida shehatae XYL1 genes, APPL MICR B, 55(1), 2001, pp. 76-80
Authors:
Cane, PA
de Ruiter, A
Rice, P
Wiselka, M
Fox, R
Pillay, D
Citation: Pa. Cane et al., Resistance-associated mutations in the human immunodeficiency virus type 1subtype C protease gene from treated and untreated patients in the United Kingdom, J CLIN MICR, 39(7), 2001, pp. 2652-2654
Authors:
Mutimer, D
Feraz-Neto, BH
Harrison, R
O'Donnell, K
Shaw, J
Cane, P
Pillay, D
Citation: D. Mutimer et al., Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir, GUT, 49(6), 2001, pp. 860-863
Authors:
Mutimer, D
Dowling, D
Cane, P
Ratcliffe, D
Tang, H
O'Donnell, K
Shaw, J
Elias, E
Pillay, D
Citation: D. Mutimer et al., Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection, ANTIVIR TH, 5(4), 2000, pp. 273-277
Authors:
Chakrabarti, S
Collingham, KE
Holder, K
Oyaide, S
Pillay, D
Milligan, DW
Citation: S. Chakrabarti et al., Parainfluenza virus type 3 infections in hematopoetic stem cell transplantrecipients: Response to ribavirin therapy, CLIN INF D, 31(6), 2000, pp. 1516-1518
Authors:
Opoku, AR
Geheeb-Keller, M
Lin, J
Terblanche, SE
Hutchings, A
Chuturgoon, A
Pillay, D
Citation: Ar. Opoku et al., Preliminary screening of some traditional Zulu medicinal plants for antineoplastic activities versus the HepG2 cell line, PHYTOTHER R, 14(7), 2000, pp. 534-537
Authors:
Pillay, D
Cane, PA
Ratcliffe, D
Atkins, M
Cooper, D
Citation: D. Pillay et al., Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study, AIDS, 14(9), 2000, pp. 1111-1116